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Abstract
Objective—To evaluate the incidence and
characteristics of musculoskeletal mani-
festations in polymyalgia rheumatica
(PMR) and temporal arteritis (TA).
Methods—The records of 163 cases of
PMR or TA diagnosed over a 15 year
period in one area of Spain were reviewed
for the presence and type of musculo-
skeletal manifestations.
Results—Of 163 patients, 90 had isolated
PMR and 73 had TA. Eighteen of the 90
patients (20%) with isolated PMR devel-
oped distal peripheral arthritis either at
diagnosis or during the course of the
disease. When it occurred, synovitis was
mild, monoarticular or pauci-articular,
asymmetrical, transient, and not destruc-
tive. Other distal manifestations observed
in these patients were carpal tunnel
syndrome and distal extremity swelling
with pitting oedema. In all cases these
manifestations occurred in conjunction
with active PMR. As expected, PMR was
the most frequent musculoskeletal mani-
festation in patients with TA, occurring in
56% of cases. On the contrary, only 11% of
patients with TA developed peripheral
arthritis. An important finding was that
peripheral arthritis in these patients ap-
pears to be linked only temporally to the
presence of simultaneous PMR and is not
observed in its absence. Distal extremity
swelling or defined polyarthritis were not
observed.
Conclusion—The spectrum of distal mus-
culoskeletal manifestations of PMR in our
series is similar to that reported in other
populations. By contrast, distal musculo-
skeletal symptoms are uncommon in TA.
The almost complete absence of distal
musculoskeletal manifestations in pa-
tients with pure TA suggests diVerent
mechanisms of disease in PMR and TA,
supporting the view of two separate condi-
tions or one common disease in which
host susceptibility influences the clinical
expression.
(Ann Rheum Dis 2001;60:1060–1063)
There is controversy as to whether polymyalgia
rheumatica (PMR) and temporal arteritis (TA)
are expressions of the same disease or are two
diVerent, partly overlapping, diseases. PMR is
a common syndrome of the elderly character-
ised by pain and stiVness involving the neck,
shoulder and pelvic girdles, generally accompa-
nied by constitutional symptoms and a raised
erythrocyte sedimentation rate. The cause of
musculoskeletal pain in PMR is not completely
understood, but inflammation in proximal
joints and periarticular structures is a likely
basis for much of the discomfort since, to date,
there is little evidence to suggest that the
musculoskeletal symptoms are related to under-
lying vasculitis. Evidence of proximal articular
and periarticular synovitis has been demon-
strated by scanning, MRI, arthroscopy, and
synovial biopsy.1–3 Moreover, an increasing
number of reports have underlined the presence
of peripheral synovitis and other distal muscu-
loskeletal manifestations in PMR, suggesting
that the spectrum of musculoskeletal involve-
ment in this entity is not completely defined and
is broader than has often been thought
previously.4–8 The clinical predominance of
proximal symptoms in PMR has probably over-
shadowed the less well characterised and more
variable distal musculoskeletal manifestations.4
TA is a vasculitis of large and medium sized
vessels with a predisposition to the cranial
arteries in patients older than 50 years.
Although cranial and ocular symptoms are the
most prominent manifestations in TA,
musculoskeletal findings, especially those of
PMR, are also common. However, controversy
exists over the presence of distal musculoskel-
etal manifestations in TA and two recent stud-
ies have produced conflicting results. Salvarini
et al, in a population based study at the Mayo
Clinic, reported common and varied distal
musculoskeletal symptoms in TA which sug-
gested that the nature of this condition and its
clinical expression are broader than has often
been considered, and supporting the link
between TA and PMR.9 By contrast, Gran et al,
in a recent prospective study conducted in
Norway, noted the particular absence of
peripheral arthritis in this group of patients.10
The occurrence of peripheral arthritis in PMR
and not in TA may reflect diVerent mecha-
nisms of disease.
In view of these contradictory observations,
we have reviewed the musculoskeletal manifes-
tations in a well defined cohort of 163 patients
with PMR and/or TA diagnosed over a 15 year
period in an eVort to provide an accurate clini-
cal picture of the frequency and clinical
spectrum of these manifestations, and have
compared our results with those reported in
other major studies of this condition.
Methods
We retrospectively analysed all patients with
PMR and/or TA diagnosed from 1985 to 1999
by the Department of Rheumatology of
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Bellvitge Hospital, Barcelona, Spain. The diag-
nosis of PMR was based on the criteria
proposed by Chuang et al.11 Patients were con-
sidered to have PMR if they met these criteria
and had a rapid and persistent response to
corticosteroid treatment. The presence of other
diseases that might explain the symptoms such
as chronic infection, connective tissue diseases,
or malignancy excluded the diagnosis of PMR.
The diagnosis of TA was made according to the
1990 ACR criteria.12 Patients were diagnosed
as having TA if they had a positive artery biopsy
specimen or, in cases with a negative biopsy or
no biopsy, if they fulfilled the remaining four
criteria and had a prompt and persistent
response to corticosteroid treatment.
After diagnosis all selected patients under-
went periodic examinations at the outpatient
clinic until death or cessation of treatment and
permanent disease remission. All patients were
examined by a rheumatologist.
Inpatient and outpatient charts of all pa-
tients were reviewed comprehensively to obtain
clinical, laboratory, and disease evolution data
according to a specifically designed protocol.
The end point of patient follow up was the date
of the last clinic visit or the date of death. In all
selected patients we recorded information on
the presence and type of musculoskeletal
manifestations, their relationship to the onset
and course of the disease, and their response to
treatment. We have not included in the study
the presence of arthralgias since the high
frequency of degenerative disease in this elderly
population would make its interpretation diY-
cult. We have also excluded those patients with
peripheral arthritis in whom, after examination
of joint fluid and/or radiological study, the
symptoms could be related to crystal associ-
ated arthritis or severe osteoarthritis.
STATISTICAL ANALYSIS
A comparative study between patients with and
without musculoskeletal manifestations was
performed using the Student’s t test for
independent continuous variables or the
Mann-Whitney U test when the assumption of
normality was not realised. To analyse categori-
cal data we performed the ÷2 test or the Fisher’s
exact test when the expected values were less
than 5. Statistical significance was defined as
p<0.05.
Results
From 1985 to 1999 inclusive a total of 163
patients (107 women) were diagnosed with TA
and/or PMR. Of these, 73 had TA and 90 had
isolated PMR. The mean (SD) age at time of
diagnosis for all patients was 72 (8) years
(range 51–89) and the mean duration of symp-
toms prior to the diagnosis was 2.7 (2.6)
months. The main clinical features and labora-
tory data of most of these patients have been
extensively reported elsewhere.13
PATIENTS WITH ISOLATED PMR
Eighteen of the 90 patients (20%) with pure
PMR developed clinically detectable periph-
eral synovitis in whom crystal arthritis and
osteoarthritis were excluded. Table 1 lists the
joints involved. These patients presented non-
deforming monoarthritis or oligoarthritis in-
volving mainly wrists and knees or, less
frequently, the sternoclavicular joints, elbows,
or some metacarpophalangeal (MCP) or proxi-
mal interphalangeal (PIP) joints. None of them
developed defined polyarthritis during the
study. All of the patients presented with
peripheral manifestations at the time of diagno-
sis and only two of the 18 had a second episode
of peripheral symptoms when PMR relapsed.
None of these patients presented with periph-
eral manifestations while proximal symptoms
of PMR were absent.
Synovitis was transient and mild, usually
asymmetrical, and resolved completely after
corticosteroid therapy was started or the pred-
nisone dose was increased. Rheumatoid factor
was negative in all cases. No erosive changes or
juxta-articular osteoporosis were seen on plain
radiographs of aVected joints. Two patients
(2%) with synovitis of the wrists referred
symptoms of acute carpal tunnel syndrome.
Finally, only one of the 18 patients (1%) devel-
oped distal symmetrical swelling of the upper
limbs with pitting oedema over the dorsum of
the hands and wrists concurrently with proxi-
mal PMR symptoms. In this patient MRI
examination showed severe extensor tenosyno-
vitis with peritendinous oedema, without
evidence of concomitant wrist or hand joint
synovitis. HLA B7 was negative. Corticoster-
oids were given and the swelling responded
promptly. No residual contractures were ob-
served.
PATIENTS WITH TEMPORAL ARTERITIS
Forty one of the 73 patients (56%) developed
PMR at some time during the course of their
TA. As in patients with pure PMR, shoulder
pain was the most frequent feature being
observed in 100% of the patients, while the
hips and neck were less commonly aVected.
In 33 patients PMR began concurrently (<1
month from the diagnosis of TA), in one PMR
began at some time after TA was diagnosed as
a result of one relapse, and in seven patients
PMR began before TA. These seven patients
were originally diagnosed as having isolated
PMR because none presented with clinical evi-
dence of TA (in none of them was a temporal
artery biopsy specimen taken at the time of
diagnosis). One suVered an arteritic recurrence
26 months after the end of a 29 month course
of treatment. The remaining six experienced an
arteritic relapse during the course of steroid
Table 1 Joints involved during 20 episodes of peripheral
arthritis in 90 patients with isolated polymyalgia
rheumatica (PMR) and during eight episodes of peripheral
arthritis in 73 patients with temporal arteritis (TA)
Joint Isolated PMR TA
Knee 11 (55%) 4 (50%)
Wrist 7 (35%) 4 (50%)
Metacarpophalangeal 5 (25%) 2 (25%)
Proximal
interphalangeal 3 (20%) –
Elbow 1 (5%) 2 (25%)
Sternoclavicular 2 (10%) 2 (25%)
Ankle – 1 (12.5%)
Data are presented as number (%) of episodes.
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treatment (median time to relapse from initia-
tion of therapy 26 (16) weeks). Relapses
usually occurred during the tapering of the
prednisone dose or as a consequence of an
unauthorised discontinuation of treatment
(n=1). In these seven cases arteritis was
confirmed by a positive biopsy specimen.
Eight of the 73 patients with TA (11%)
developed clinically detectable synovitis. Inter-
estingly, all of these patients also had PMR.
Table 1 lists the joints involved. In six a
non-deforming, self-limited mono or asym-
metrical oligoarthritis was observed, aVecting
mainly knees and wrists or, less frequently,
elbows or some MCP or PIP joints. The
remaining two patients presented with tender-
ness and mild swelling of both sternoclavicular
joints. No erosive changes were seen on plain
radiographs of the aVected joints, although
erosions in the sternoclavicular joints were
confirmed by tomography in two patients. All
of the eight patients developed peripheral
manifestations concurrently with the time
proximal PMR began. In all cases synovitis was
transient and this manifestation resolved com-
pletely after corticosteroid treatment was
started. Clinical symptoms suggesting carpal
tunnel syndrome were observed in one patient
(1%) with synovitis of the wrists. Distal
extremity swelling, tenosynovitis, or defined
polyarthritis were not observed in any patient.
COMPARISONS BETWEEN PATIENTS WITH AND
WITHOUT MUSCULOSKELETAL MANIFESTATIONS
At the time of diagnosis patients with PMR and
distal musculoskeletal manifestations did not
diVer from those without these features. In
comparing patients with TA and musculoskel-
etal symptoms with those without, we observed
that the group with musculoskeletal findings
seemed to have more severe disease character-
ised by a greater increase in erythrocyte
sedimentation rate, lower values of haemo-
globin, and an increased incidence of constitu-
tional symptoms, jaw claudication, and visual
problems, although these diVerences were no
longer statistically significant (table 2).
Discussion
There is considerable controversy regarding
the frequency of peripheral synovitis in PMR
since its reported incidence varies consider-
ably, ranging from 6% to 60% in various
series.4–7 These discrepancies may be attributed
to the variable use of diVerent diagnostic crite-
ria for PMR (with important selection bias in
the ascertainment of PMR cases), the defini-
tion of synovitis (which has been equated with
arthralgia in some studies), and diYculty in the
interpretation of scans and radiographs due to
coexisting degenerative disease. In our series,
20% of patients with isolated PMR developed
clinically detectable peripheral arthritis either
at diagnosis or during the course of the disease.
This percentage is very similar to those
reported in previous observations.4 5 7 In all of
these cases peripheral synovitis occurred in
conjunction with active PMR, particularly at its
onset or, less frequently, during a relapse. The
data suggest that synovitis is not uncommon in
PMR, and seems to be a main contributing
factor to many of the symptoms seen in
patients with this condition. When it occurred,
synovitis presented as mono or asymmetrical
oligoarthritis involving mainly wrists and
knees. Unlike rheumatoid arthritis, synovitis
was transient and mild, non-deforming, and
resolved completely after corticosteroid treat-
ment was started or the prednisone dose was
increased. None of the patients developed
defined polyarthritis. Rheumatoid factor was
negative in all cases. No erosive changes or
juxta-articular osteoporosis were seen on plain
radiographs of aVected joints. Although it has
been suggested that the presence of peripheral
Table 2 Comparison between patients with and without distal musculoskeletal manifestations
(A) Patients with isolated PMR
Patients with distal
musculoskeletal manifestations
n=18 (20%)
Patients without distal
musculoskeletal manifestations
n=72 (80%) p Value
Mean (SD) age at onset of disease (years) 71.3 (9) 71.8 (8) NS
F:M ratio 12/6 (2) 46/26 (1.8) NS
Malaise/anorexia/weight loss 9 (50%) 40 (55%) NS
Low grade fever 1 (6%) 6 (8%) NS
Mean (SD) ESR (mm/h) 72 (23) 74 (20) NS
Mean (SD) haemoglobin (g/l) 116 (13) 118 (12) NS
Raised alkaline phosphatase 4 (22%) 12 (17%) NS
Raised ALT/AST 2 (11%) 6 (8%) NS
(B) Patients with TA
Patients with musculoskeletal
manifestations n=41 (56%)
Patients without
musculoskeletal manifestations
n=32 (44%) p Value
Mean (SD) age at onset of disease (years) 71.4 (8) 73 (9) NS
F:M ratio 28/13 (2.1) 21/11 (1.9) NS
Headache 41 (100%) 32 (100%) NS
Abnormal temporal artery 35 (85%) 29 (90%) NS
Jaw claudication 17 (41%) 8 (25%) NS
Malaise/anorexia/weight loss 27 (66%) 19 (59%) NS
Fever 7 (17%) 2 (6%) NS
Amaurosis fugax 10 (24%) 4 (12%) NS
Mean (SD) ESR (mm/h) 91 (24) 80 (21) NS
Mean (SD) haemoglobin (g/l) 110 (13) 115 (14) NS
Raised alkaline phosphatase 10 (24%) 7 (22%) NS
Raised ALT/AST 5 (12%) 3 (9%) NS
PMR = polymyalgia rheumatica; TA = temporal arteritis; ESR = erythrocyte sedimentation rate; ALT/AST = alanine
aminotransferase/aspartate aminotransferase; SD = standard deviation.
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arthritis in PMR is associated with a longer
duration of steroid treatment and a higher fre-
quency of relapses indicating a subset with
more severe disease,5 in our series patients with
PMR and distal musculoskeletal manifesta-
tions did not diVer from those without them.
Other distal manifestations observed in
patients with isolated PMR were carpal tunnel
syndrome and distal extremity swelling with
pitting oedema. The incidence of carpal tunnel
syndrome described in previous reports ranges
from 6% to 14%, being mainly attributed to
wrist flexor tenosynovitis.4–6 11 In our popula-
tion this percentage was substantially lower
(2%) and in these patients carpal tunnel
syndrome resulted mainly from synovitis of the
wrists. Distal extremity swelling with pitting
oedema represents another clinical feature
recently recognised in PMR; in our series only
1% of patients with isolated PMR had distal
swelling with pitting oedema compared with an
incidence of 8–12% in earlier reports.4 5 8 We
cannot completely explain the low incidence of
distal extremity swelling in our patients. A ret-
rospective review such as this is inevitably
associated with a bias toward underreporting of
these features. In this regard, it is reasonable to
assume that some manifestations, especially
those less recognisable or unfamiliar, may have
been overlooked. However, the patients were
carefully evaluated at regular intervals and,
since the presence of any of these manifesta-
tions generally implies significant pain and
functional impairment of the patient and are
easily detectable on physical examination, it
seems likely most occurrences would have been
reported in the medical records and therefore
included in this study. Alternatively, this diVer-
ence may simply reflect the variability in mus-
culoskeletal manifestations of PMR in diVerent
populations. In this sense, our findings are in
close agreement with Gran et al who also
observed a low frequency of distal pitting
oedema (0.4%) in a recent prospective study
conducted in Norway.10 The reason for this
variability among diVerent populations may
well be genetic.
As expected, PMR with proximal aching and
morning stiVness was the most frequent
musculoskeletal manifestation in patients with
TA, occurring in 56% of cases. In addition to
the frequent proximal symptoms, only 11% of
patients with TA developed distal peripheral
arthritis. This percentage was lower than that
reported in a population based study recently
conducted at the Mayo Clinic (23%).9 The
clinical characteristics and distribution of
peripheral joint inflammation observed in these
patients were similar to those described in the
group with isolated PMR. With the exception
of the sternoclavicular joints, no erosive
changes were seen. In comparing patients with
musculoskeletal symptoms with those without,
we observed that the group with peripheral
arthritis seemed to have more severe disease
characterised by more laboratory abnormali-
ties reflecting inflammation and increased inci-
dence of constitutional symptoms, jaw claudi-
cation, and visual problems. Interestingly, an
important finding was that peripheral joint
involvement was only present in conjunction
with active PMR and was not observed when
PMR was absent. The particular absence of
peripheral arthritis in patients with isolated TA
has also been observed previously by several
authors10 and may, to some extent, indicate
important diVerences in the aetiopathogenesis
of PMR and TA. Moreover, distal extremity
swelling with pitting oedema was not observed
in any case and, contrary to other reports that
have described both seronegative and seroposi-
tive rheumatoid arthritis in patients with
TA,9 14 15 none of our patients developed
defined polyarthritis during the study.
In summary, although the frequency of distal
musculoskeletal manifestations observed in
our patients with PMR was diVerent from that
given in some previous reports, overall the
findings of this study support and confirm the
similar findings found in diVerent populations
with this condition. However, in contradiction
to another major study of this condition,9 we
found that distal musculoskeletal manifesta-
tions in patients with TA were uncommon.
Peripheral synovitis in these patients appears to
be linked only temporally to the presence of
simultaneous PMR. The almost complete
absence of peripheral arthritis and other distal
musculoskeletal manifestations in patients with
pure TA suggests diVerent mechanisms of dis-
ease in PMR and TA, supporting the view of
two separate conditions or one common
disease in which host susceptibility influences
the clinical expression. Further studies in other
populations are needed to confirm our results.
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